Philips Medical and Huawei promote Internet + health care development
Recently, Philips (China) Investment Co., Ltd. and Huawei officially signed a strategic cooperation agreement. The two sides will form an industry alliance in the health care and cloud service markets, and carry out all-round cooperation in the “health care†process covering healthy lifestyle, disease prevention, diagnosis, treatment and home care. It is understood that the two parties will integrate Philips' professional experience and system platform in personal health care and disease diagnosis and management, as well as Huawei's mature and complete IT infrastructure construction, Internet of Things technology and cloud service capabilities, through mutual opening of the market and sharing of customers. Collaborative methods such as resource and product joint development and market introduction, comprehensive cooperation in “Health Careâ€, including digital hospital construction, post-doctoral management, home-based care, medical-grade wearable devices, hospital cloud services, provincial and municipal levels Promotion and application of medical cloud platforms. In the field of professional medical care, the two sides will rely on Philips' resources in diagnostic imaging, patient monitoring, pathology research, clinical data, etc., to leverage Huawei's resources in diagnostic imaging, patient monitoring, pathology research, and clinical data to leverage Huawei's powerful interoperability, data storage, and high performance. Calculate and other advantages, through the connection of patients, equipment, and data, jointly create a digital hospital solution, promote the pilot construction of digital hospitals, and improve the service quality and efficiency of medical institutions. Prifenidone Intermediates Pirfenidone Cas 53179-13-8,Pirfenidone Intermediate,Cas 1603-41-4 Pirfenidone Intermediate,Cas 1003-68-5 Pirfenidone Shijiazhuang Dingmin pharmaceutical Sciences Co.,Ltd , https://www.dingminpharma.com